Oskar Koperek

3PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 05, 2025
HER2/CEP17 ratio predicts residual cancer burden after neoadjuvant dual HER2 blockade: real-world data in patients with primary HER2-amplified breast cancer.

Myriam Stolz, Alex Farr, Kristina A Tendl-Schulz

|Nov 27, 2019
A Nomogram to Predict the Outcome of Fine Needle Aspiration Cytology in Head and Neck Masses.

Ulana Kotowski, Faris F Brkic, Oskar Koperek

Pageof 1